Over-the-Counter and Prescription Nausea Management Options If dietary and behavioral changes don't fully resolve nausea, several safe, evidence-supported medications can help
The bottom line: the research on GLP-1 medications and blood clot risk is genuinely mixed
Tirzepatide , a dual GIP/GLP-1 receptor agonist, demonstrated superior efficacy to semaglutide in a landmark head-to-head trial, with patients receiving ZEPBOUND losing an average of 50 pounds over 72 weeks compared with 33 pounds among WEGOVY-treated patients
The role of fiber in energy balance
This is expected and is part of how the medication works, but it makes monitoring important for people with diabetes
This cost barrier forces healthcare providers in cost-sensitive markets to rely on cheaper alternatives, impacting the growth potential of GLP-1 drugs